Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05016232 · ClinicalTrials.gov registry record · NA

Adaptive Intervention to Facilitate PrEP Uptake/Adherence Among Transgender Women

A NA study of Prevention, sponsored by University of California, Los Angeles.

Completed
Registry status
NA
Development phase
123
Enrollment target
1
Study location

NCT05016232 is a NA study of Prevention that has completed, run by University of California, Los Angeles. The registered enrollment target is 123 participants, below the 49,981-participant average among 11 other Prevention trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05016232, a NA study of Prevention, has completed, sponsored by University of California, Los Angeles.

COMPLETED
Registry status
NA
Development phase
123 participants
Enrollment target
1
Study location

Study Summary

"PrEP N' Shine" is a two-stage randomized controlled pilot trial which utilizes a behavioral intervention to optimize the uptake and adherence of Pre-exposure Prophylaxis (PrEP) in Transgender women (TGW).

Conditions Studied

Interventions

  • BEHAVIORAL PrEP N' Shine: Strength Based Case Management (Stage 1)
  • BEHAVIORAL PrEP N' Shine: Stepped Adherence Training and Counseling (Stage 2)

Study Locations (1)

California

  • UCLA Center for LGBTQ+ Advocacy, Research & Health - Los Angeles

Trial Details

FieldValue
Enrollment Target 123 participants
Start Date 2022-10-18
Est. Completion 2024-06-30
Phase NA

What the Registry Record Tells You About NCT05016232

The ClinicalTrials.gov registry entry for NCT05016232 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 123 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 49,981-participant average among 11 other Prevention trials with a reported enrollment target (100% lower). The listed sponsor is University of California, Los Angeles, which has 897 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Prevention appearing as the primary indexed condition, and to 2 interventions - of which PrEP N' Shine: Strength Based Case Management (Stage 1) is the first listed.

NCT05016232 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT05016232 about?

NCT05016232 is a clinical study titled "Adaptive Intervention to Facilitate PrEP Uptake/Adherence Among Transgender Women". "PrEP N' Shine" is a two-stage randomized controlled pilot trial which utilizes a behavioral intervention to optimize the uptake and adherence of Pre-exposure Prophylaxis (PrEP) in Transgender women (TGW).

What is the current status of trial NCT05016232?

This trial is currently completed. It is a NA study. The enrollment target is 123 participants. The study started on 2022-10-18. Estimated completion is 2024-06-30.

What conditions does trial NCT05016232 study?

This clinical trial studies the following conditions: Prevention.

What interventions are being tested in trial NCT05016232?

The interventions under investigation include: PrEP N' Shine: Strength Based Case Management (Stage 1) (BEHAVIORAL), PrEP N' Shine: Stepped Adherence Training and Counseling (Stage 2) (BEHAVIORAL).

Who is sponsoring clinical trial NCT05016232?

This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05016232 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Prevention

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.